The G319S variants of the HNF1A gene in a family with diabetes mellitus
- Authors: Ivanoshctak D.E1,2, Mikhailova S.V1, Ovsyannikova A.K2, Shakhtshneider E.V1,2, Druk I.V3, Rymar O.D2, Voevoda M.I4
-
Affiliations:
- Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
- Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
- Omsk State Medical University of the Ministry of Healthcare of Russia
- Federal Research Center for Fundamental and Translational Medicine
- Issue: Vol 7, No 9 (2021)
- Pages: 148-154
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288646
- DOI: https://doi.org/10.18565/therapy.2021.9.148-154
- ID: 288646
Cite item
Abstract
Full Text
About the authors
D. E Ivanoshctak
Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences; Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
Email: dinara20840mailru
630090, Novosibirsk, 10 Akademika Lavrentieva Avenue. Tel.: +7 (961) 874-12-16
S. V Mikhailova
Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
Email: mikhaiirabionet.nsc.ru
Novosibirsk, 10 Prospect Akademika Lavrentieva Avenue. Tel.: +7 (913) 91024-63
A. K Ovsyannikova
Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences630089, Novosibirsk, 175/1 Borisa Bogatkova Str. Tel.: +7 (383) 373-09-89
E. V Shakhtshneider
Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences; Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
Email: 2117409ramail.ru
630089, Novosibirsk, 175/1 Borisa Bogatkova Str. Tel..: +7 (383) 373-09-82
I. V Druk
Omsk State Medical University of the Ministry of Healthcare of Russia
Email: osma-genpract0yandex.ru
644033, Omsk, 127/1 Krasny Put' Str. Tel.: +7 (381) 249-20-85
O. D Rymar
Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
Email: orymar230gmail.com
630089, Novosibirsk, 175/1 Borisa Bogatkova Str. Tel.: +7 (383) 373-09-89
M. I Voevoda
Federal Research Center for Fundamental and Translational Medicine
Email: mvoevoda0ya.ru
630117, Novosibirsk, 2 Timakova Str
References
- Дедов И.И., Шестакова М.В., Майоров А.Ю. с соавт. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 9-й выпуск. Сахарный диабет. 2019; S1-1: 1-144. @@Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition. Sakharnyy diabet = Diabetes. 2019; S1-1: 1-144 (In Russ.). https://dx.doi.org/10.14341/DM221S1.
- Yang Y., Chan L. Monogenic diabetes: What it teaches us on the common forms of type 1 and type 2 diabetes. Endocr Rev. 2016; 37(3): 190-222. doi: 10.1210/er.2015-1116.
- Lachance C.H. Practical aspects of monogenic diabetes: A clinical point of view. Can J Diabetes. 2016; 40(5): 368-75. doi: 10.1016/j. jcjd.2015.11.004.
- Mohan V., Radha V. Precision diabetes is slowly becoming a reality. Med Princ Pract. 2019; 28(1): 1-9. doi: 10.1159/000497241.
- Shields B.M., Hicks S., Shepherd M.H. et al. Maturity-onset diabetes of the young (MODY): How many cases are we missing? Diabetologia. 2010; 53(12): 2504-08. doi: 10.1007/s00125-010-1799-4.
- Firdous P., Nissar K., Ali S. et al. Genetic testing of maturity-onset diabetes of the young current status and future perspectives. Front Endocrinol (Lausanne). 2018; 9: 253. doi: 10.3389/fendo.2018.00253.
- Ellard S., Bellanne-Chantelot C., Hattersley A.T. European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008; 51(4): 546-53. doi: 10.1007/s00125-008-0942-y.
- Stride A., Shields B., Gill-Carey O. et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 2014; 57(1): 54-56. doi: 10.1007/s00125-013-3075-x.
- Воевода М.И., Рымар О.Д., Шатшнейдер Е.А. с соавт. Диагностика и ведение пациентов с диабетом MODY: методические рекомендации для врачей. Н.: Издательство СО РАН. 2020; 48 с. @@Voevoda M.I., Rymar O.D., Shatshneider E.A. et al. Diagnosis and management of patients with diabetes MODY: guidelines for doctors. N: Publishing house of the SB RAS. 2020; 48 pp. (In Russ.).
- Bach I., Mattei M.G., Cereghini S., Yaniv M. Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res. 1991; 19(13): 3553-59. doi: 10.1093/nar/19.13.3553.
- Chi Y.I., Frantz J.D., Oh B.C. et al. Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol Cell. 2002; 10(5): 1129-37. doi: 10.1016/s1097-2765(02)00704-9.
- Vaxillaire M., Abderrahmani A., Boutin P. et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem. 1999; 274(50): 35639-46. doi: 10.1074/jbc.274.50.35639.
- Bach I., Yaniv M. More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO J. 1993; 12(11): 4229-42. Erratum in: EMBO J 1994; 13(2): 492.
- Pontoglio M., Sreenan S., Roe M. et al. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest. 1998; 101(10): 2215-22. doi: 10.1172/JCI2548.
- Pontoglio M. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J Am Soc Nephrol. 2000; 11 Suppl 16: S140-43.
- Harries L.W., Ellard S., Stride A. et al. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet. 2006; 15(14): 2216-24. doi: 10.1093/hmg/ddl147.
- Shepherd M., Ellis I., Ahmad A.M. et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med. 2001; 18(5): 417-21. doi: 10.1046/j.1464-5491.2001.00447.x.
- Owen K.R., Shepherd M., Stride A. et al. Heterogeneity in young adult onset diabetes: Aetiology alters clinical characteristics. Diabet Med. 2002; 19(9): 758-61. doi: 10.1046/j.1464-5491.2002.00766.x.
- Sambrook J., Russell D.W. Purification of nucleic acids by extraction with phenol: Chloroform. CSH Protoc. 2006; 2006(1): pdb. prot4455. doi: 10.1101/pdb.prot4455.
- Ivanoshchuk D.E., Shakhtshneider E.V., Rymar O.D. et al. The mutation spectrum of maturity onset diabetes of the young (MODY)-associated genes among Western Siberia patients. J Pers Med. 2021; 11(1): 57. doi: 10.3390/jpm11010057.
- Pajak A., Szafraniec K., Kubinova R. et al. Binge drinking and blood pressure: cross-sectional results of the HAPIEE study. PLoS One. 2013; 8(6): e65856. doi: 10.1371/journal.pone.0065856.
- Баранова А. А., Друк И. В., Овсянникова А. К. Описание клинических случаев семейной формы сахарного диабета HNF1A-MODY. Лечащий врач. 2020; 12: 35-40. @@Baranova A.A., Druk I.V., Ovsyannikova A.K. Description of clinical cases of the familial form of HNF1A-MODY diabetes mellitus. Lechashchiy vrach = Attending physician. 2020; 12: 35-40 (In Russ.). https://dx.doi.org/10.26295/OS.2020.13.48.008.
- Hegele R.A., Cao H., Harris S.B. et al. The hepatic nuclear factor-1 alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 1999; 84(3): 1077-82. doi: 10.1210/jcem.84.3.5528.
- Harris S.B., Gittelsohn J., Hanley A. et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997; 20(2): 185-87. doi: 10.2337/diacare.20.2.185.
- Lau H.H., Ng N.H.J., Loo L.S.W. et al. The molecular functions of hepatocyte nuclear factors - in and beyond the liver. J Hepatol. 2018; 68(5): 1033-48. doi: 10.1016/j.jhep.2017.11.026.
- Hegele R.A., Cao H., Harris S.B. et al. The private hepatocyte nuclear factor-1 alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arterioscler Thromb Vasc Biol. 2000; 20(1): 217-22. doi: 10.1161/01.atv.20.1.217.
- Harries L.W., Sloman M.J., Sellers E.A. et al. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts. Diabetes. 2008; 57(7): 1978-82. doi: 10.2337/db07-1663. www.rnmot.ru
- GoodSmith M.S., Skandari M.R., Huang E.S., Naylor R.N. The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing. Diabetes Care. 2019; 42(12): 2247-55. doi: 10.2337/dc19-0486.